Australians living with MS will be represented by a single national body as MS Australia and its research subsidiary MS Research Australia are brought closer together.

Australian scientists are using cutting-edge technologies to discover previously unknown human cells that may play a role in MS.

The Pharmaceutical Benefits Advisory Committee will meet in July to discuss the inclusion of two MS medications on the Pharmaceutical Benefits Scheme.

Narelle and Nathan, a mother-son duo, are conquering The May 50K as part of accepting Nathan’s MS diagnosis and to raise funds for MS research.

$1 million funding boost towards MS research into myelin repair and neuroprotective research in Australia that will pave the way to end MS forever.

The Pharmaceutical Benefits Advisory Committee has announced disappointing outcomes for PBS inclusion of certain MS medications following its March meeting.

People with MS sharing their data with their healthcare teams accelerates our understanding of MS in the COVID-19 era and this data drives COVID-19 advice.

Proteins on the surface of early myelin producing cells are vital for their survival and may be important in finding ways to repair damage from MS.